nodes	percent_of_prediction	percent_of_DWPC	metapath
Ephedrine—ADRA1A—Endothelin Pathways—ADCY10—nephrolithiasis	0.0483	0.0614	CbGpPWpGaD
Ephedrine—SLC18A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A12—nephrolithiasis	0.0306	0.039	CbGpPWpGaD
Ephedrine—SLC18A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A9—nephrolithiasis	0.0285	0.0362	CbGpPWpGaD
Ephedrine—ADRB2—Monoamine GPCRs—CHRM3—nephrolithiasis	0.0242	0.0308	CbGpPWpGaD
Ephedrine—Ventricular fibrillation—Hydrochlorothiazide—nephrolithiasis	0.0219	0.102	CcSEcCtD
Ephedrine—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A12—nephrolithiasis	0.0206	0.0262	CbGpPWpGaD
Ephedrine—ADRB2—Amine ligand-binding receptors—CHRM3—nephrolithiasis	0.0204	0.0259	CbGpPWpGaD
Ephedrine—SLC18A2—SLC-mediated transmembrane transport—SLC26A6—nephrolithiasis	0.0201	0.0255	CbGpPWpGaD
Ephedrine—ADRA1A—Monoamine GPCRs—CHRM3—nephrolithiasis	0.02	0.0255	CbGpPWpGaD
Ephedrine—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A9—nephrolithiasis	0.0192	0.0244	CbGpPWpGaD
Ephedrine—SLC18A2—SLC-mediated transmembrane transport—SLC3A1—nephrolithiasis	0.0184	0.0234	CbGpPWpGaD
Ephedrine—SLC18A2—SLC-mediated transmembrane transport—SLC34A3—nephrolithiasis	0.0184	0.0234	CbGpPWpGaD
Ephedrine—ADRA1A—Amine ligand-binding receptors—CHRM3—nephrolithiasis	0.0168	0.0214	CbGpPWpGaD
Ephedrine—ADRB2—Calcium Regulation in the Cardiac Cell—RGS14—nephrolithiasis	0.0149	0.0189	CbGpPWpGaD
Ephedrine—SLC18A2—SLC-mediated transmembrane transport—SLC34A1—nephrolithiasis	0.0139	0.0177	CbGpPWpGaD
Ephedrine—SLC18A2—SLC-mediated transmembrane transport—SLC22A12—nephrolithiasis	0.0139	0.0177	CbGpPWpGaD
Ephedrine—SLC6A2—NRF2 pathway—SLC2A9—nephrolithiasis	0.0138	0.0176	CbGpPWpGaD
Ephedrine—SLC6A2—SLC-mediated transmembrane transport—SLC26A6—nephrolithiasis	0.0135	0.0172	CbGpPWpGaD
Ephedrine—SLC18A2—SLC-mediated transmembrane transport—SLC2A9—nephrolithiasis	0.0129	0.0165	CbGpPWpGaD
Ephedrine—SLC18A2—SLC-mediated transmembrane transport—SLC26A1—nephrolithiasis	0.0129	0.0165	CbGpPWpGaD
Ephedrine—SLC6A2—SLC-mediated transmembrane transport—SLC3A1—nephrolithiasis	0.0124	0.0157	CbGpPWpGaD
Ephedrine—SLC6A2—SLC-mediated transmembrane transport—SLC34A3—nephrolithiasis	0.0124	0.0157	CbGpPWpGaD
Ephedrine—ADRA1A—Calcium Regulation in the Cardiac Cell—RGS14—nephrolithiasis	0.0123	0.0156	CbGpPWpGaD
Ephedrine—SLC18A2—SLC-mediated transmembrane transport—SLC7A9—nephrolithiasis	0.0115	0.0147	CbGpPWpGaD
Ephedrine—SLC18A2—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.0114	0.0146	CbGpPWpGaD
Ephedrine—SLC18A2—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.0114	0.0146	CbGpPWpGaD
Ephedrine—ADRB2—GPCRs, Other—CHRM3—nephrolithiasis	0.0108	0.0137	CbGpPWpGaD
Ephedrine—Angina pectoris—Hydrochlorothiazide—nephrolithiasis	0.0103	0.0479	CcSEcCtD
Ephedrine—SLC18A2—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.0102	0.013	CbGpPWpGaD
Ephedrine—Dysuria—Hydrochlorothiazide—nephrolithiasis	0.00986	0.046	CcSEcCtD
Ephedrine—SLC6A2—SLC-mediated transmembrane transport—SLC22A12—nephrolithiasis	0.00936	0.0119	CbGpPWpGaD
Ephedrine—SLC6A2—SLC-mediated transmembrane transport—SLC34A1—nephrolithiasis	0.00936	0.0119	CbGpPWpGaD
Ephedrine—SLC18A2—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.00933	0.0119	CbGpPWpGaD
Ephedrine—SLC18A2—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.00933	0.0119	CbGpPWpGaD
Ephedrine—Sweating—Hydrochlorothiazide—nephrolithiasis	0.00901	0.0421	CcSEcCtD
Ephedrine—SLC6A2—SLC-mediated transmembrane transport—SLC2A9—nephrolithiasis	0.0087	0.0111	CbGpPWpGaD
Ephedrine—SLC6A2—SLC-mediated transmembrane transport—SLC26A1—nephrolithiasis	0.0087	0.0111	CbGpPWpGaD
Ephedrine—Bradycardia—Hydrochlorothiazide—nephrolithiasis	0.00859	0.0401	CcSEcCtD
Ephedrine—SLC6A2—SLC-mediated transmembrane transport—SLC7A9—nephrolithiasis	0.00776	0.00987	CbGpPWpGaD
Ephedrine—SLC6A2—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.0077	0.0098	CbGpPWpGaD
Ephedrine—SLC6A2—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.0077	0.0098	CbGpPWpGaD
Ephedrine—ADRB2—G alpha (s) signalling events—PTH—nephrolithiasis	0.00769	0.00978	CbGpPWpGaD
Ephedrine—Arrhythmia—Hydrochlorothiazide—nephrolithiasis	0.00754	0.0352	CcSEcCtD
Ephedrine—ADRB2—Calcium Regulation in the Cardiac Cell—CHRM3—nephrolithiasis	0.00725	0.00923	CbGpPWpGaD
Ephedrine—Tension—Hydrochlorothiazide—nephrolithiasis	0.00721	0.0336	CcSEcCtD
Ephedrine—Nervousness—Hydrochlorothiazide—nephrolithiasis	0.00713	0.0333	CcSEcCtD
Ephedrine—SLC18A2—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.00707	0.009	CbGpPWpGaD
Ephedrine—SLC18A2—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.00707	0.009	CbGpPWpGaD
Ephedrine—Muscle spasms—Hydrochlorothiazide—nephrolithiasis	0.00706	0.033	CcSEcCtD
Ephedrine—ADRA1A—G alpha (q) signalling events—DGKH—nephrolithiasis	0.00692	0.00881	CbGpPWpGaD
Ephedrine—Tremor—Hydrochlorothiazide—nephrolithiasis	0.00688	0.0321	CcSEcCtD
Ephedrine—SLC6A2—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00686	0.00874	CbGpPWpGaD
Ephedrine—Agitation—Hydrochlorothiazide—nephrolithiasis	0.00675	0.0315	CcSEcCtD
Ephedrine—Vertigo—Hydrochlorothiazide—nephrolithiasis	0.0066	0.0308	CcSEcCtD
Ephedrine—SLC18A2—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.00657	0.00837	CbGpPWpGaD
Ephedrine—SLC18A2—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.00657	0.00837	CbGpPWpGaD
Ephedrine—Palpitations—Hydrochlorothiazide—nephrolithiasis	0.00649	0.0303	CcSEcCtD
Ephedrine—SLC6A2—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.00628	0.00799	CbGpPWpGaD
Ephedrine—SLC6A2—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.00628	0.00799	CbGpPWpGaD
Ephedrine—Chest pain—Hydrochlorothiazide—nephrolithiasis	0.00625	0.0292	CcSEcCtD
Ephedrine—Anxiety—Hydrochlorothiazide—nephrolithiasis	0.00623	0.0291	CcSEcCtD
Ephedrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—DGKH—nephrolithiasis	0.00619	0.00788	CbGpPWpGaD
Ephedrine—Confusional state—Hydrochlorothiazide—nephrolithiasis	0.00605	0.0282	CcSEcCtD
Ephedrine—ADRA1A—Calcium Regulation in the Cardiac Cell—CHRM3—nephrolithiasis	0.006	0.00764	CbGpPWpGaD
Ephedrine—SLC18A2—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.00586	0.00746	CbGpPWpGaD
Ephedrine—SLC18A2—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.00586	0.00746	CbGpPWpGaD
Ephedrine—Tachycardia—Hydrochlorothiazide—nephrolithiasis	0.00585	0.0273	CcSEcCtD
Ephedrine—Hyperhidrosis—Hydrochlorothiazide—nephrolithiasis	0.0058	0.027	CcSEcCtD
Ephedrine—Anorexia—Hydrochlorothiazide—nephrolithiasis	0.00571	0.0267	CcSEcCtD
Ephedrine—Insomnia—Hydrochlorothiazide—nephrolithiasis	0.00542	0.0253	CcSEcCtD
Ephedrine—Dyspnoea—Hydrochlorothiazide—nephrolithiasis	0.00534	0.0249	CcSEcCtD
Ephedrine—Dyspepsia—Hydrochlorothiazide—nephrolithiasis	0.00528	0.0246	CcSEcCtD
Ephedrine—Decreased appetite—Hydrochlorothiazide—nephrolithiasis	0.00521	0.0243	CcSEcCtD
Ephedrine—Pain—Hydrochlorothiazide—nephrolithiasis	0.00513	0.0239	CcSEcCtD
Ephedrine—ADRA1A—G alpha (q) signalling events—CHRM3—nephrolithiasis	0.005	0.00637	CbGpPWpGaD
Ephedrine—Feeling abnormal—Hydrochlorothiazide—nephrolithiasis	0.00494	0.0231	CcSEcCtD
Ephedrine—SLC6A2—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.00476	0.00605	CbGpPWpGaD
Ephedrine—SLC6A2—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.00476	0.00605	CbGpPWpGaD
Ephedrine—Body temperature increased—Hydrochlorothiazide—nephrolithiasis	0.00474	0.0221	CcSEcCtD
Ephedrine—SLC18A2—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.00468	0.00596	CbGpPWpGaD
Ephedrine—ADRB2—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.00468	0.00595	CbGpPWpGaD
Ephedrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—CHRM3—nephrolithiasis	0.00448	0.0057	CbGpPWpGaD
Ephedrine—SLC6A2—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.00442	0.00563	CbGpPWpGaD
Ephedrine—SLC6A2—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.00442	0.00563	CbGpPWpGaD
Ephedrine—Asthenia—Hydrochlorothiazide—nephrolithiasis	0.0043	0.0201	CcSEcCtD
Ephedrine—ADRB2—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.00401	0.0051	CbGpPWpGaD
Ephedrine—Dizziness—Hydrochlorothiazide—nephrolithiasis	0.00396	0.0185	CcSEcCtD
Ephedrine—SLC6A2—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.00394	0.00502	CbGpPWpGaD
Ephedrine—SLC6A2—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.00394	0.00502	CbGpPWpGaD
Ephedrine—ADRA1A—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.00387	0.00492	CbGpPWpGaD
Ephedrine—Vomiting—Hydrochlorothiazide—nephrolithiasis	0.00381	0.0178	CcSEcCtD
Ephedrine—Rash—Hydrochlorothiazide—nephrolithiasis	0.00378	0.0176	CcSEcCtD
Ephedrine—Dermatitis—Hydrochlorothiazide—nephrolithiasis	0.00378	0.0176	CcSEcCtD
Ephedrine—Headache—Hydrochlorothiazide—nephrolithiasis	0.00376	0.0175	CcSEcCtD
Ephedrine—Nausea—Hydrochlorothiazide—nephrolithiasis	0.00356	0.0166	CcSEcCtD
Ephedrine—ADRB2—GPCR downstream signaling—RGS14—nephrolithiasis	0.00353	0.00449	CbGpPWpGaD
Ephedrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.00331	0.00422	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—RGS14—nephrolithiasis	0.00321	0.00408	CbGpPWpGaD
Ephedrine—SLC6A2—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.00315	0.00401	CbGpPWpGaD
Ephedrine—ADRB2—GPCR ligand binding—CHRM3—nephrolithiasis	0.00305	0.00388	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—RGS14—nephrolithiasis	0.00292	0.00372	CbGpPWpGaD
Ephedrine—ADRB2—GPCR ligand binding—PTH—nephrolithiasis	0.00279	0.00355	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—GRHPR—nephrolithiasis	0.00277	0.00352	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—RGS14—nephrolithiasis	0.00265	0.00337	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR ligand binding—CHRM3—nephrolithiasis	0.00252	0.00321	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—GRHPR—nephrolithiasis	0.00247	0.00314	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—AGXT—nephrolithiasis	0.00246	0.00314	CbGpPWpGaD
Ephedrine—ADRB2—GPCR downstream signaling—DGKH—nephrolithiasis	0.00238	0.00303	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR ligand binding—PTH—nephrolithiasis	0.00231	0.00294	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—ADCY10—nephrolithiasis	0.00223	0.00283	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—AGXT—nephrolithiasis	0.0022	0.0028	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—DGKH—nephrolithiasis	0.00217	0.00276	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—SLC26A1—nephrolithiasis	0.0021	0.00267	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—APRT—nephrolithiasis	0.0021	0.00267	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—DGKH—nephrolithiasis	0.00197	0.00251	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—RGS14—nephrolithiasis	0.00189	0.00241	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—APRT—nephrolithiasis	0.00187	0.00238	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—SLC26A1—nephrolithiasis	0.00187	0.00238	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—ADCY10—nephrolithiasis	0.00184	0.00234	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—DGKH—nephrolithiasis	0.00179	0.00228	CbGpPWpGaD
Ephedrine—ADRB2—GPCR downstream signaling—CHRM3—nephrolithiasis	0.00172	0.00219	CbGpPWpGaD
Ephedrine—ADRB2—GPCR downstream signaling—PTH—nephrolithiasis	0.00158	0.00201	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—RGS14—nephrolithiasis	0.00157	0.00199	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—CHRM3—nephrolithiasis	0.00157	0.00199	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—AQP1—nephrolithiasis	0.00149	0.0019	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—PTH—nephrolithiasis	0.00143	0.00182	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—CHRM3—nephrolithiasis	0.00143	0.00181	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—CHRM3—nephrolithiasis	0.00135	0.00172	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—AQP1—nephrolithiasis	0.00133	0.0017	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—PTH—nephrolithiasis	0.0013	0.00166	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—CHRM3—nephrolithiasis	0.0013	0.00165	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.00128	0.00163	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—DGKH—nephrolithiasis	0.00128	0.00163	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—CHRM3—nephrolithiasis	0.0012	0.00153	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—PTH—nephrolithiasis	0.00118	0.00151	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—DGKH—nephrolithiasis	0.00106	0.00135	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.00106	0.00135	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—CHRM3—nephrolithiasis	0.000925	0.00118	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—PTH—nephrolithiasis	0.000846	0.00108	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—CHRM3—nephrolithiasis	0.000765	0.000974	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—PTH—nephrolithiasis	0.0007	0.00089	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—SPP1—nephrolithiasis	0.000425	0.00054	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—SPP1—nephrolithiasis	0.000351	0.000447	CbGpPWpGaD
